Mizuri Taki

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki et al. · Circulation · 2022 · 59 citations · Full text

Medicine, Cardiology, Internal Medicine +13

New Conversion Formula Between B-Type Natriuretic Peptide and N-Terminal-Pro-B-Type Natriuretic Peptide　― Analysis From a Multicenter Study ―

Satomi Ishihara, Shinya Hiramitsu, Koshiro Kanaoka et al. · Circulation Journal · 2022 · 35 citations · Full text

Medicine, Cardiology, Clinical Cardiology +6

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Sex Differences in the Prognostic Power of Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide for Cardiovascular Events　― The Japan Morning Surge-Home Blood Pressure Study ―

Mizuri Taki, Yusuke Ishiyama, Hiroyuki Mizuno et al. · Circulation Journal · 2018 · 15 citations · Full text

Medicine, Cardiology, Internal Medicine +11